![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
Purpose: The aim was to evaluate central corneal thickness in patients with meibomian gland dysfunction.
Methods: The study group was made up of 40 eyes of 20 patients with meibomian gland dysfunction (mean age, 40.55 ± 10.7-years). Forty eyes of 20 healthy individuals (mean age, 39.25 ± 11.1-years) without any ophthalmic or systemic pathology were used as a control group. The central corneal thickness was measured with ultrasonic pachymetry.
Results: The mean central corneal thickness was 541.45 ± 24.68 µm in the study group and 544.30 ± 22.16 µm in the control group. There was no statistically significant difference in the mean central corneal thickness measurements in the meibomian gland dysfunction group in comparison with the control group (p > 0.05).
Conclusion: Central corneal thickness measurements do not differ in patients with meibomian gland dysfunction compared with healthy control subjects.
This paper was presented in part at the 17th Congress of the European Society of Ophthalmology, Amsterdam, The Netherlands, 13–16 June 2009.
This paper was presented in part at the 17th Congress of the European Society of Ophthalmology, Amsterdam, The Netherlands, 13–16 June 2009.
Notes
This paper was presented in part at the 17th Congress of the European Society of Ophthalmology, Amsterdam, The Netherlands, 13–16 June 2009.